We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
PolyPeptide and Donaldson collaborate to develop solvent recovery system for peptide purification
13 May 2024 - MINNEAPOLIS / TORRANCE, Calif. May 13, 2024 – Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and […]
Read moreResearch article: Synthesis of Peptides by Reactive Extrusion. Application to the Continuous and Solventless Preparation of Aspartame.
25 Apr 2024 - The latest results from an innovative mechanochemical approach to continuous and solventless peptide synthesis. PolyPeptide is dedicated to applying relevant principles of green chemistry to mitigate […]
Read morePolyPeptide announces results of the annual General Meeting 2024
10 Apr 2024 - Baar, 10 April 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced that the shareholders […]
Read morePolyPeptide participates in industry effort to advance sustainability
26 Mar 2024 - Increasing manufacturing volume requirements and the high process mass intensity (PMI) of peptide synthesis warrants continued industry efforts for more sustainable production processes. PolyPeptide collaborated with […]
Read morePolyPeptide publishes invitation to the annual General Meeting 2024
19 Mar 2024 - Baar, 19 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, published today the invitation to […]
Read morePolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow
12 Mar 2024 - Baar, 12 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced its results for […]
Read moreGreen Chemistry Articles of Interest to the Pharmaceutical Industry
22 Feb 2024 - Org. Process Res. Dev. 2024, 28, 652–660 Ashley, M. A.; Aukland, M. H.; Bryan, M. C.; Cismesia, M. A.; Dutschei, T.; Engl, O. D.; Engl, P. […]
Read morePolyPeptide signs scientific collaboration agreement
31 Oct 2023 - Strasbourg, 31 October 2023 – PolyPeptide today announced the signing of a collaboration agreement with the Peptide Sciences Laboratory of the University of KwaZulu-Natal (UKZN) in […]
Read morePolyPeptide secures revolving credit facility
2 Oct 2023 - Baar, 2 October 2023 – PolyPeptide Group AG (SIX: PPGN) announces the signing of a revolving credit facility agreement with Credit Suisse, Danske Bank and Zürcher […]
Read more